Cerebrospinal Fluid Management Market, Production Value, Analysis 2024

Mounting number of shunting procedures, quick advancements in continuing research projects associated to brain barriers and fluids, mounting occurrence of neurological disorders, and mounting occurrence of hydrocephalus are the primary growth drivers for cerebrospinal fluid management market.

North America is the largest cerebrospinal fluid management market as in the region the occurrence of hydrocephalus increasing. Mounting funding for hydrocephalus research, mounting occurrence of neurological disorders, expanding geriatric population, mounting demand for minimally invasive procedure, rapid technological advancement and the initiate of organizations are also up surging growth of the North American cerebrospinal fluid management market.

Asia-Pacific is observed to witness the fastest growth in the market, due to mounting occurrence of hydrocephalus and increasing awareness about neurological diseases. 

Key players in the cerebrospinal fluid management market are catering to the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In May 2016, Medtronic PLC, received FDA clearance for StrataMR valves and shunts, for treatment of patients with hydrocephalus and cerebrospinal fluid disorders.

Medtronic PLC, Spiegelberg GmbH & Co. Kg, Deltasurgical, Integra Lifesciences Holdings Corporation, Natus Medical Incorporated, G.SURGIWEAR LTD, B. Braun Melsungen, Dispomedica GmbH, SOPHYSA, Moller Medical GmbH, and Wellong Instruments Co., Ltd are the key players offering cerebrospinal fluid management.

Source: VynZ Research